Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00084318 · FLOW

Participant flow

Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck · Source last updated 2018-12-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Loading dose of cetuximab followed by radiation therapy with weekly cisplatin and cetuximab.
    id
    FG000
    title
    RT + Cisplatin + Cetuximab
  2. description
    Loading dose of cetuximab followed by radiation therapy (RT) with weekly docetaxel and cetuximab.
    id
    FG001
    title
    RT + Docetaxel + Cetuximab
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        2
      type
      Withdrawal by Subject
    2. reasons
      1. group Id
        FG000
        num Subjects
        15
      2. group Id
        FG001
        num Subjects
        11
      type
      Protocol Violation
    3. reasons
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        0
      type
      No protocol treatment
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        119
      2. group Id
        FG001
        num Subjects
        119
      type
      STARTED
    2. achievements
      1. comment
        Subjects with data available for the primary analysis are considered to have completed the study.
        group Id
        FG000
        num Subjects
        97
      2. comment
        Subjects with data available for the primary analysis are considered to have completed the study.
        group Id
        FG001
        num Subjects
        106
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        22
      2. group Id
        FG001
        num Subjects
        13
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Loading dose of cetuximab followed by radiation therapy with weekly cisplatin and cetuximab.
    id
    FG000
    title
    RT + Cisplatin + Cetuximab
  2. description
    Loading dose of cetuximab followed by radiation therapy (RT) with weekly docetaxel and cetuximab.
    id
    FG001
    title
    RT + Docetaxel + Cetuximab
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        2
      type
      Withdrawal by Subject
    2. reasons
      1. group Id
        FG000
        num Subjects
        15
      2. group Id
        FG001
        num Subjects
        11
      type
      Protocol Violation
    3. reasons
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        0
      type
      No protocol treatment
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        119
      2. group Id
        FG001
        num Subjects
        119
      type
      STARTED
    2. achievements
      1. comment
        Subjects with data available for the primary analysis are considered to have completed the study.
        group Id
        FG000
        num Subjects
        97
      2. comment
        Subjects with data available for the primary analysis are considered to have completed the study.
        group Id
        FG001
        num Subjects
        106
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        22
      2. group Id
        FG001
        num Subjects
        13
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice